Condition

Pre-Eclampsia

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 214 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials214

Recruiting24

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

Internal Jugular Vein Collapsibility Index for Volume Status Assessment in Preeclampsia in Correlation With Normotensive ParturientsNCT07786246 · 2025-10-01

Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With PreeclampsiaNCT06893510 · 2025-09-08

Autophagy/Apoptosis Balance in Placental Vascular PathologiesNCT06779916 · 2025-05-02

A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)NCT06785116 · 2025-03-02

Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy HistoryNCT06821685 · 2025-02-13

Ultrasound Airway Assessment of Critically Ill Preeclamptic; Comparison Between Two TechniqueNCT06651879 · 2024-07-20

Physical Activity to Mitigate PreEclampsia RiskNCT06319014 · 2024-06-24

APPLE: Aspirin to Prevent Pregnancy Loss and PreeclampsiaNCT06408181 · 2024-06-12

Treatment With Aspirin After Preeclampsia: TAP TrialNCT06281665 · 2024-05-29

Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in ChinaNCT06414655 · 2024-03-01

Multi-Omics for Maternal Health After PreeclampsiaNCT06340152 · 2023-12-20

Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese PatientsNCT06067906 · 2023-11-02

Role of Anti-C1q Autoantibodies in PregnancyNCT06317467 · 2023-09-13

Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant WomenNCT04520048 · 2023-08-11

Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive TechnologyNCT05625724 · 2023-08-02

Pilot Study of Microvesicles in Pre-eclamptic and Non-pre-eclamptic Women With Threatened Preterm DeliveryNCT05675969 · 2023-05-31

At High-risk for Pre-eclampsia After Assisted Reproductive TechnologyNCT05746793 · 2023-02-15

PEPPI Study: Identification of Women at Risk for Placental DysfunctionNCT06115122 · 2022-02-15

Early Prediction of Preeclampsia Using arteriaL Stiffness in High-risk prEgnanciesNCT04783597 · 2021-07-12

Clinical Antenatal Randomised Study to CharactErise Key Roles of TetrahydroFOLate in HyperTensive PregnanciesNCT05434195 · 2021-06-01

Chronic Hypertension and Acetyl Salicylic Acid in PregnancyNCT04356326 · 2021-02-15

Mechanisms of Pregnancy Vascular AdaptationsNCT03806283 · 2018-11-20

Study of the Physiology of Pre-eclampsia and Vascular IUGR With Constitution of a Biological CollectionNCT03626233 · 2018-08-06

PlacEntal Acute Atherosis RefLecting Subclinical AtherosclerosisNCT05500989 · 2016-11-01

Glucose and Blood Pressure During PregnancyNCT04979312 · 2026-08-01

Acute Beetroot Juice Supplementation in Pre-eclampsia PregnanciesNCT06387784 · 2026-05-18

NOT_YET_RECRUITING

Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset PreeclampsiaNCT07245056 · 2025-12-01

Mortality Outcome of Controlled HypertensionNCT07187596 · 2025-09-18

ACTIVE_NOT_RECRUITING

Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia.NCT06122220 · 2025-08-15

Effect of Albumin Versus Routine Care on Hemodynamic Response and Stability in Patients With Preeclampsia Guided by a Non-invasive Hemodynamic Monitoring System During Cesarean Delivery With Spinal AnesthesiaNCT06107335 · 2025-07-01

NOT_YET_RECRUITING

DM199 for Pregnancy ComplicationsNCT06875141 · 2025-05-01

Are There Sleep-related Factors That Contribute to an Increased Incidence of Pre-eclampsia at Altitude?NCT06702475 · 2025-04-01

NOT_YET_RECRUITING

co Ihibtory Receptor in PreeclampsiaNCT05294952 · 2025-01-01

Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of PregnancyNCT06523569 · 2024-11-07

ACTIVE_NOT_RECRUITING

Brain Health in MidlifeNCT06640842 · 2024-09-23

Inferior Vena Cava Collapsibility Index Guide for Preoperative Fluid Therapy in PreeclampsiaNCT06539026 · 2024-08-15

Preeclampsia Intervention NetherlandsNCT06452498 · 2024-08-01

NOT_YET_RECRUITING

Role of Vaspin in Pathophysiology of Pre-eclampsiaNCT06437535 · 2024-06-01

Classical Turkish Music for Pregnant Women With PreeclampsiaNCT06315985 · 2024-03-20

LEARNER- Low dosE AspiRiN prEterm tRial (Angola)NCT06417411 · 2024-03-16

ACTIVE_NOT_RECRUITING

Homocysteine in Critically Ill PreeclampsiaNCT06413576 · 2024-01-19

Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant WomenNCT06180811 · 2024-01-02

Hydroxychloroquine May be Beneficial for PreeclampsiaNCT06020378 · 2024-01-01

ACTIVE_NOT_RECRUITING

Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 WeeksNCT06108947 · 2024-01-01

ACTIVE_NOT_RECRUITING

Optimal Blood Pressure Treatment Thresholds PostpartumNCT06069102 · 2023-11-15

Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in NewbornsNCT06653374 · 2023-11-12

CONNEQT Pulse Validation StudyNCT06002971 · 2023-08-21

Low Dose Aspirin for Prevention of Early Pregnancy LossNCT06261203 · 2023-07-01

Eliminating Severe Maternal Morbidity With Heart Health Doulas TrialNCT05655936 · 2023-06-29

ACTIVE_NOT_RECRUITING

sFlt-1/PlGF Ratio: Impact on the Management of Patients With Suspected Pre-eclampsiaNCT05228002 · 2023-05-23

Body Fat Index for Obstetric Risk StratificationNCT05533996 · 2023-03-01

Evaluation of HALP Score in PreeclampsiaNCT05816044 · 2023-02-22

Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of PreeclampsiaNCT06214702 · 2023-01-07

Midkine Role With Deregulated Oxidative and Immune Milieu in Induction of PreeclampsiaNCT06329284 · 2023-01-01

Maternal Serum Stathmin-1 Levels in PreeclampsiaNCT06623955 · 2023-01-01

Prostasin Levels in Preeclamptic WomenNCT06623942 · 2023-01-01

Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic WomenNCT05622838 · 2022-12-01

State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis AssaysNCT05625763 · 2022-11-15

Vital Mechanism of NETs Formation vs. Suicidal Mechanism of NETs Formation During Normal Pregnancy and PreeclampsiaNCT05470712 · 2022-07-20

LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)NCT04762992 · 2022-07-18

ENROLLING_BY_INVITATION

Common interventions

Leading sponsors

Assiut University 11 University of Oxford 6 Ain Shams Maternity Hospital 4 Ain Shams University 4 Cairo University 4 Centre Hospitalier Universitaire de Nīmes 4 Maastricht University Medical Center 4 National Heart, Lung, and Blood Institute (NHLBI) 4 Aswan University Hospital 3 Centre Hospitalier Intercommunal Creteil 3 Hadassah Medical Organization 3 McGill University Health Centre/Research Institute of the McGill University Health Centre 3 Yale University 3 Alisse Hauspurg 2 Başakşehir Çam & Sakura City Hospital 2

Trial status mix

COMPLETED97

UNKNOWN64

RECRUITING24

TERMINATED10

ACTIVE_NOT_RECRUITING9

NOT_YET_RECRUITING4

WITHDRAWN4

ENROLLING_BY_INVITATION1

SUSPENDED1

Phase mix

NA72

PHASE317

PHASE416

PHASE211

PHASE15

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.